Home / Software / Trial Simulator

Trial Simulator™

Prevent rejections in the late stages of drug development and maximize your chances of success.

Optimizing trial design for better outcomes

9 out of 10 drugs in development fail, costing billions annually, with late-stage failures being the most expensive due to prior investments. A key factor in these failures is sub-optimal trial design.

Certara’s Clinical Trial Simulator has been trusted for over a decade by leading pharmaceutical companies to optimize trial design and maximize the probability of success. By leveraging simulation and existing knowledge of the drug under study, Trial Simulator provides critical insights to improve study endpoints and reduce trial costs.

Streamline trial processes to improve efficiency and resource use

Optimize dosing and treatment schedules

Increase the probability of meeting study endpoints

Enhance trial design with a full suite of tools

Trial Simulator empowers researchers to design and optimize clinical trials with ease. It offers tools to create and compare study designs, access pre-built models, and conduct advanced analyses like ANOVA, bioequivalence, and Kaplan-Meier survival analysis. With features for population-based drug and disease modeling and support for various trial designs, including crossover and parallel studies, it streamlines trial planning and execution.

Generate detailed statistics

Create graphical summaries

Explore “what if” scenarios to refine strategies and ensure robust outcomes

How PK/PD scientist benefit

Optimize trial design

Trial Simulator provides a full suite of tools to model drug action, build population-based drug and disease models, and describe drug actions over time in subjects.

Protocol design flexibility

Supports a variety of trial designs, including parallel, n-by-n Latin square, and crossover designs, to meet your study needs.

Integrated study analysis plans

Create and analyze calculated field variables, handle missing data, and explore “what if” scenarios to refine your trial strategy.

Related products

Create collaborative, compliant clinical trial designs with Pinnacle 21 Enterprise.

The modern PK/PD modeling software for today’s scientists, Phoenix NLME streamlines pharmacokinetic and pharmacodynamic modeling.

A trusted solution for pharmacokinetic, pharmacodynamic, and non-compartmental analysis.

Phoenix Hosted delivers faster compute, outsourced validation, and flexibility of access across Mac and PC operating systems.

Pharmacokinetic and pharmacodynamic data analysis

Certara is proud to offer a golden opportunity for learners and experts in pharmacokinetics & pharmacodynamics! Prof Johan Gabrielsson’s standard book will be available FREE of charge!

Get your free ebook

Related resources

View all

1 / 4

Blog

How Clinical Trial Software Helps Make Studies More Efficient

2 / 4

On-Demand Webinar

Data-Backed Trial Design– Applying AI to Clinical Outcome Analysis

Global spending on clinical trials is expected to reach $68.9 billion per year by 2025 with the average phase 1 asset taking 10.5 years to reach regulatory approval. As the...

Watch now

3 / 4

Brochure

Phoenix NLME, The Modern PK/PD Modeling Software for Today’s Scientists

Phoenix NLME is the PK/PD modeling software that is user-friendly and easy-to-learn. Built from the ground up on the Phoenix workbench architecture, Phoenix NLME enables users to focus on modeling, and not on the tools or coding required to implement the modeling. The result is more time for analysis and strategic decision-making.

4 / 4

Brochure

Pirana Modeling Workbench

Pirana is a flexible and extendible modeling workbench with an intuitive graphical user interface for facilitating pharmacometric workflows for NONMEM, PsN, Xpose/R, and more. Pirana’s research tools facilitate the iterative processes used to create Pop PK/PD models, resulting in better organization and more efficient analysis of results.

Schedule a demo

Discover how Certara’s Clinical Trial Simulation Software can transform your trial design process.

Reduce trial costs and improve efficiency

Refine dosing and treatment schedules

Enhance the likelihood of achieving study endpoints